#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

SYNDROM UVEÁLNÍ EFUZE. KAZUISTIKA


Authors: A. Konrád;  M. Penčák;  M. Veith;  P. Studený
Authors place of work: Oftalmologická klinika Fakultní nemocnice Královské Vinohrady a 3. lékařské fakulty Univerzity Karlovy v Praze
Published in the journal: Čes. a slov. Oftal., 77, 2021, No. 4, p. 202-206
Category: Case Report
doi: https://doi.org/10.31348/2021/23

Summary

Purpose: Purpose of this article is to present a case report of a patient with uveal effusion syndrome who underwent deep posterior sclerotomy.

Case report: A 73-year-old patient with unilateral decrease in the best corrected visual acuity, ablation of choroid and secondary retinal detachment in the right eye was admitted to our clinic for examination in November 2017. At the first examination, the best corrected visual acuity in the right eye was 0.3, in the left eye 1.0. Intraocular pressure was 16 mmHg in the right eye and 21 mmHg in the left eye. After performing ultrasound biomicroscopy of the anterior segment (Accutome, Keeler, USA), ultrasound sonography of the affected eye (Accutome, Keeler, USA), magnetic resonance imaging, computed tomography, abdominal ultrasound and blood tests, we concluded the finding as uveal effusion syndrome. We initiated a conservative treatment consisting of oral administration of carbonic anhydrase inhibitor in combination with topical use of prostaglandin analogue. Despite conservative treatment the best corrected visual acuity of the affected eye decreased to 0.05 so we proceeded to a surgical procedure – deep posterior sclerotomy with perioperative scleral sampling for histological examination (detection of glycosaminoglycans in the sclera wall by Alcian blue staining), which was negative. This histological result ranks the patient as the third type of uveal effusion syndrome (ie, non-nanophthalmic with a normal sclera). After the operation both the ablation of choroid and retinal detachment reattached and the best corrected visual acuity in the right eye improved to 0.3. After the subsequent cataract surgery, the ablation of choroid and retinal detachment occurred again, this time with spontaneous recovery. Postoperatively, the best corrected visual acuity in the right eye was 0.5 and at the last check-up at our clinic 0.6.

Conclusion: Deep posterior sclerotomy is a method of choice of surgical treatment for uveal effusion syndrome that does not respond to conservative therapy.

Keywords:

uvea – uveal effusion syndrome – deep posterior sclerotomy – secondary retinal detachment


Zdroje
  1. Chan W, Fang-tian D, Hua Z, You-xin C, Rong-ping D, Ke T. Diagnosis and treatment of uveal effusion syndrome: a case series and literature review. Chin Med Sci J. 2011;26(4):231-236.
  2. Palestine A, Cao J, Tripathy K, Skvortsova NA. Uveal Effusion Syndrome. American Academy of Ophthalmology. Available from: https://eyewiki.aao.org/Uveal_effusion_syndrome
  3. Kong M, Kim JH, Kim SJ, Kang SW. Full-thickness sclerotomy for uveal effusion syndrome. Korean J Ophthalmol. 2013;27(4):294-298.
  4. https://youtu.be/B4Ltyg6XV6I
  5. Shields CL, Roelofs K, Di Nicola M, Sioufi K, Mashayekhi A, Shields JA. Uveal effusion syndrome in 104 eyes: Response to corticosteroids – The 2017 Axel C. Hansen lecture. Indian J Ophthalmol. 2017;65(11):1093-1104.
  6. Elagouz M, Stanescu-Segall D, Jackson TL. Uveal effusion syndrome. Surv Ophthalmol. 2010;55(2):134-145.
  7. Moldow B, Sander B, Larsen M, Lund-Andersen H. Effects of acetazolamide on passive and active transport of fluorescein across the normal BRB. Invest Ophthalmol Vis Sci. 1999;40(8):1770-1775.
  8. Derk BA, Benčić G, Corluka V, Geber MZ, Vatavuk Z. Medical therapy for uveal effusion syndrome. Eye (Lond). 2014;28(8):1028-1031.
  9. Bodnar Z, Mruthyunjaya P. Management of Uveal Effusion Syndome. Retina Today. 2018 September. Available from: https://retinatoday.com/articles/2018-sept/management-of-uveal-effusion-syndrome
  10. Yue BYJT, Duvall J, Goldberg MF, Puck A, Tso MOM, Sugar J. Nanophthalmic sclera. Morphologic and tissue culture studies. Ophthalmology. 1986;93(4):534-541.
  11. Uyama M, Takahashi K, Kozaki J, et al. Uveal effusion syndrome: clinical features, surgical treatment, histologic examination of the sclera, and pathophysiology. Ophthalmology. 2000;107(3):441-449.
  12. Gass JDM, Jallow S. Idiopathic serous detachment of the choroid, ciliary body, and retina (uveal effusion syndrome). Ophthalmology. 1982;89:1018-1032.
  13. Říhová E, Boguszáková J, Gajdošíková Z, Šišková A, Šplíchal L. Syndrom idiopatické uveální efuze [Idiopathic Uveal Effusion Syndrome]. Cesk Slov Oftalmol. 2000;(1):11-17. Czech.
  14. Šišková A, Říhová E, Dotřelová D, Adam P. Perforující pars plana sklerotomie u syndromu idiopatické uveální efúze [Perforating Pars Plana Sclerotomy in Idiopathic Uveal Effusion Syndrome]. Cesk Slov Oftalmol. 2005;(3):172-178. Czech.
  15. Johnson MW, Gass JDM. Surgical management of the idiopathic uveal effusion syndrome. Ophthalmology. 1990;97:778-785.
  16. Jackson TL, Hussain A, Morley AMS, et al. Scleral hydraulic conductivity and macromolecular diffusion in patients with uveal effusion syndrome. Invest Ophthalmol Vis Sci. 2008;49(11):5033-5040.
  17. Sabrosa NA, Smith HB, MacLaren RE. Scleral punch method with topical mitomycin C for safe revision of failed deep sclerectomy in nanophthalmic uveal effusion syndrome. Graefes Arch Clin Exp Ophthalmol. 2009;247(7):999-1001.
  18. Akduman L, Adelberg DA, Del Priore LV. Nanophthalmic uveal effusion managed with scleral windows and topical mitomycin-C. Ophthalmic Surg Lasers. 1997;28(4):325-327.
  19. Suzuki Y, Nishina S, Azuma N. Scleral window surgery and topical mitomycin C for nanophthalmic uveal effusion complicated by renal failure: case report. Graefes Arch Clin Exp Ophthalmol. 2007;245(5):755-757.
  20. Bausili MM, Raja H, Kotowski J, et al. Use of fiberoptic-guided CO2 laser in the treatment of uveal effusion. Retin Cases Brief Rep. 2017;11(3):191-194.
Štítky
Ophthalmology
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#